News

The rolling biologics license application (BLA) submission is seeking clearance to market Provenge (sipuleucel-T) for the treatment of asymptomatic patients with metastatic, androgen-independent (also known as hormone-refractory) prostate

Theratechnologies launched its TH9507 pivotal phase III program in March 2005. The first 412-patient clinical trial began in June 2005 and patient enrolment at 43 clinical sites across

Barr’s three year battle to sell the drug over-the-counter has caused considerable controversy in the US with some groups claiming that easier access to the drug would promote

Teva said this step is designed to further improve efficiencies, supply chain management and competitive positioning following the company’s $7.4 billion acquisition of Ivax in January 2006. Through

If the proof is validated, it will solve the ages-old mystery of what provokes black pigment gallstones, and, Nanobac hopes, forge a path to effective early diagnosis and

Many pregnant women get prescriptions for non-steroidal anti-inflammatory drugs (NSAIDs) during their first trimester, and even more – up to 15% – take over-the-counter versions of these drugs.

In the study, 21 patients were treated to evaluate the safety of the regimen and to determine the maximum tolerated dose of Xyotax (paclitaxel poliglumex) in combination with

Keppra (levetiracetam) is widely prescribed as an add-on therapy in the treatment of partial onset seizures in adults and children four years of age and older with epilepsy.

Current methods of generating embryonic stem cells involve removing the cells from a roughly five-day-old embryo, destroying the embryo in the process. Because of moral concerns about the